Updates matching "National"

The American Cancer Society Cancer Action Network (ACS CAN) is calling on the Departments of Health and Human Services, Labor and Treasury to put cancer patients and survivors first when implementing rules around surprise medical bills.

The U.S. Food and Drug Administration issued marketing denial orders (MDOs) to 31 companies who sought to sell 300,000 flavored electronic cigarettes. The decision requires these manufacturers to remove those identified products already on the market.

The U.S. Food and Drug Administration issued its first denials of flavored electronic cigarettes after the agency determined the manufacturer’s products pose a greater risk to public health than any potential benefit.

Washington, D.C.— The DIVERSE Trials Act, introduced in both the House and Senate would increase diversity in clinical trials and make it easier for all cancer patients to participate in clinical trials. The bipartisan bicameral legislation, sponsored by Sens. Robert Menendez (D-N.J.) and Tim Scott (R-S.C.), and Reps. Raul

Today the president called on Congress to bring down patient prescription drug costs, an issue of critical importance to cancer patients. Among the provisions the president outlined was establishing an annual cap on Medicare enrollees’ out-of-pocket expenses.

Late last week the administration rescinded a proposed rule that would have tied the price of select Medicare Part B drugs to that of foreign countries. Of the 50 drugs selected for participation under the Most Favored Nation rule, 35 would have been cancer drugs.

More than two dozen patient groups and health care partners are joining forces to call for a comprehensive paid family and medical leave program, including caregiving leave.

Today the U.S. House of Representatives will begin debate on a package of funding bills for FY 2022, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

Washington, D.C. ---Today the House Appropriations Committee will vote on a proposed FY 2022 spending bill that would increase funding for the National Institutes of Health (NIH) by $6.5 billion and include a $432 million increase for the National Cancer Institute (NCI), and $194 million for the Cancer Moonshot.